Canaccord Genuity Group Cuts Greenbrook TMS (NASDAQ:GBNH) Price Target to C$4.75

Greenbrook TMS (NASDAQ:GBNHGet Rating) had its price target cut by Canaccord Genuity Group from C$6.25 to C$4.75 in a research note published on Thursday, The Fly reports.

Several other research analysts have also weighed in on the stock. Clarus Securities lowered their price objective on shares of Greenbrook TMS from C$7.50 to C$4.50 in a research note on Monday, July 18th. Stifel Nicolaus lowered their price objective on shares of Greenbrook TMS from C$8.75 to C$8.00 in a research note on Wednesday, October 19th. Finally, Lake Street Capital lowered their price objective on shares of Greenbrook TMS from $13.00 to $11.00 in a research note on Wednesday, July 20th.

Greenbrook TMS Stock Up 4.2 %

Greenbrook TMS stock opened at $2.97 on Thursday. The firm has a market capitalization of $52.87 million, a PE ratio of -1.67 and a beta of 3.20. The company’s 50-day moving average is $3.06 and its 200-day moving average is $2.49. Greenbrook TMS has a fifty-two week low of $1.27 and a fifty-two week high of $7.35. The company has a debt-to-equity ratio of 19.92, a current ratio of 0.40 and a quick ratio of 0.40.

Institutional Trading of Greenbrook TMS

Hedge funds and other institutional investors have recently modified their holdings of the stock. AdvisorShares Investments LLC boosted its holdings in Greenbrook TMS by 23.8% in the 2nd quarter. AdvisorShares Investments LLC now owns 128,256 shares of the company’s stock valued at $182,000 after purchasing an additional 24,694 shares during the period. Bank of Montreal Can bought a new stake in Greenbrook TMS in the 1st quarter valued at about $123,000. AM Investment Strategies LLC bought a new stake in Greenbrook TMS in the 1st quarter valued at about $90,000. Finally, K.J. Harrison & Partners Inc bought a new stake in Greenbrook TMS in the 3rd quarter valued at about $30,000. Institutional investors own 16.73% of the company’s stock.

About Greenbrook TMS

(Get Rating)

Greenbrook TMS Inc, together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.

Featured Articles

The Fly logo

Receive News & Ratings for Greenbrook TMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenbrook TMS and related companies with MarketBeat.com's FREE daily email newsletter.